比较不同检测方法以评估人乳头瘤病毒（HPV）感染和接种疫苗后16型和18型HPV特异性抗体。
Comparison of different assays to assess human papillomavirus (HPV) type 16- and 18-specific antibodies after HPV infection and vaccination.
作者信息
Scherpenisse Mirte, Schepp Rutger M, Mollers Madelief, Mooij Sofie H, Meijer Chris J L M, Berbers Guy A M, van der Klis Fiona R M
机构信息
Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Bilthoven, the Netherlands.
出版信息
Clin Vaccine Immunol. 2013 Aug;20(8):1329-32. doi: 10.1128/CVI.00153-13. Epub 2013 Jun 5.
Abstract
We compared the measurement of human papillomavirus (HPV)-specific serum antibody levels with the virus-like-particle multiplex immunoassay (VLP-MIA), competitive Luminex immunoassay (cLIA), and glutathione S-transferase (GST) L1-based MIA. Using a large panel of serum samples, these assays showed mutually good correlations for both naturally induced and vaccine-derived HPV-specific antibody levels. However, an adaptation of the GST L1-based MIA resulted in an improved correlation with both cLIA and VLP-MIA.
摘要
我们将人乳头瘤病毒（HPV）特异性血清抗体水平的检测方法与病毒样颗粒多重免疫测定法（VLP-MIA）、竞争性Luminex免疫测定法（cLIA）以及基于谷胱甘肽S-转移酶（GST）L1的免疫测定法进行了比较。使用大量血清样本，这些检测方法在自然诱导和疫苗衍生的HPV特异性抗体水平方面均显示出良好的相互相关性。然而，对基于GST L1的免疫测定法进行改进后，其与cLIA和VLP-MIA的相关性均得到了提高。
相似文献
1
Comparison of different assays to assess human papillomavirus (HPV) type 16- and 18-specific antibodies after HPV infection and vaccination.比较不同检测方法以评估人乳头瘤病毒（HPV）感染和接种疫苗后16型和18型HPV特异性抗体。
Clin Vaccine Immunol. 2013 Aug;20(8):1329-32. doi: 10.1128/CVI.00153-13. Epub 2013 Jun 5.
2
Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.采用谷胱甘肽S-转移酶L1多重血清学检测法对HPV16/18疫苗进行免疫原性评估。
Hum Vaccin Immunother. 2014;10(10):2965-74. doi: 10.4161/21645515.2014.972811.
3
Comparison of a VLP-based and GST-L1-based multiplex immunoassay to detect vaccine-induced HPV-specific antibodies in first-void urine.基于病毒样颗粒和 GST-L1 的多重免疫分析与检测初段尿中 HPV 疫苗特异性抗体的比较。
J Med Virol. 2020 Dec;92(12):3774-3783. doi: 10.1002/jmv.25841. Epub 2020 Apr 19.
4
Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial.在一项两剂与三剂人乳头瘤病毒（HPV）疫苗试验中，通过假病毒中和试验和竞争性Luminex检测法测定的人乳头瘤病毒16型（HPV 16）和HPV 18抗体反应。
Clin Vaccine Immunol. 2011 Mar;18(3):418-23. doi: 10.1128/CVI.00489-10. Epub 2011 Jan 19.
5
Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types.用于9种人乳头瘤病毒类型的人乳头瘤病毒竞争性鲁米诺免疫测定法的开发。
Hum Vaccin Immunother. 2014;10(8):2168-74. doi: 10.4161/hv.29205.
6
Characteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclasses.HPV 特异性抗体应答的特征：感染和疫苗接种诱导的交叉反应性、中和活性、亲合力和 IgG 亚类。
PLoS One. 2013 Sep 18;8(9):e74797. doi: 10.1371/journal.pone.0074797. eCollection 2013.
7
Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial.在四价 HPV 疫苗试验中，使用假病毒中和、Merck cLIA 和 Merck 总 IgG LIA 免疫分析检测 HPV 16 和 HPV 18 抗体反应，降低剂量。
Vaccine. 2014 Jan 23;32(5):624-30. doi: 10.1016/j.vaccine.2013.09.007. Epub 2013 Sep 19.
8
Development of bead-based immunoassay to quantify neutralizing antibody for human papillomavirus 16 and 18.基于珠粒的免疫分析方法的开发，用于定量人乳头瘤病毒 16 和 18 的中和抗体。
Mol Biotechnol. 2013 Jun;54(2):361-70. doi: 10.1007/s12033-012-9571-2.
9
Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old.16至26岁男性接种四价人乳头瘤病毒（6/11/16/18型）疫苗的免疫原性。
Clin Vaccine Immunol. 2012 Feb;19(2):261-7. doi: 10.1128/CVI.05208-11. Epub 2011 Dec 7.
10
Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses.接种含AS04佐剂的宫颈癌疫苗诱导产生的抗人乳头瘤病毒16型和18型抗体的长期持续性：持续抗体反应的模型
Gynecol Oncol. 2009 Dec;115(3 Suppl):S1-6. doi: 10.1016/j.ygyno.2009.01.011. Epub 2009 Feb 12.
引用本文的文献
1
HPV-specific antibodies in female genital tract secretions captured via first-void urine retain their neutralizing capacity.通过首次尿潴留收集的女性生殖道分泌物中的 HPV 特异性抗体保留其中和能力。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2330168. doi: 10.1080/21645515.2024.2330168. Epub 2024 Apr 3.
2
Multiplex immunoassay to measure antibody response to nine HPV vaccine types.九价人乳头瘤病毒疫苗型抗体反应的多重免疫分析检测
J Immunol Methods. 2021 Nov;498:113136. doi: 10.1016/j.jim.2021.113136. Epub 2021 Aug 28.
3
Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge.HPV 疫苗接种后的长期免疫原性综述：当前知识的空白。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1908059. doi: 10.1080/21645515.2021.1908059. Epub 2021 May 25.
4
Investigating the aetiology of adverse events following HPV vaccination with systems vaccinology.应用系统疫苗学研究 HPV 疫苗接种后不良反应的病因学。
Cell Mol Life Sci. 2019 Jan;76(1):67-87. doi: 10.1007/s00018-018-2925-6. Epub 2018 Oct 16.
5
HPV SEROSTATUS PRE- AND POST-VACCINATION IN A RANDOMIZED PHASE II PREPAREDNESS TRIAL AMONG YOUNG WESTERN CAPE, SOUTH AFRICAN WOMEN: THE EVRI TRIAL.南非西开普省年轻女性中一项随机II期准备试验（EVRI试验）中接种疫苗前后的人乳头瘤病毒血清状态
Papillomavirus Res. 2017 Jun;3:50-56. doi: 10.1016/j.pvr.2017.02.001. Epub 2017 Feb 16.
6
Human Papillomavirus (HPV) L1 Serum Antibodies and the Risk of Subsequent Oral HPV Acquisition in Men: The HIM Study.人乳头瘤病毒（HPV）L1血清抗体与男性后续口腔感染HPV的风险：HIM研究
J Infect Dis. 2016 Jul 1;214(1):45-8. doi: 10.1093/infdis/jiw083. Epub 2016 Feb 29.
7
Comparisons of VLP-Based ELISA, Neutralization Assays with Native HPV, and Neutralization Assays with PsV in Detecting HPV Antibody Responses in HIV-Infected Women.基于病毒样颗粒的酶联免疫吸附测定、与天然人乳头瘤病毒的中和试验以及与伪病毒的中和试验在检测HIV感染女性中人乳头瘤病毒抗体反应方面的比较。
J AIDS Clin Res. 2015 Mar;6(3). doi: 10.4172/2155-6113.1000433.
8
Development and evaluation of multiplexed immunoassay for detection of antibodies to HPV vaccine types.用于检测人乳头瘤病毒（HPV）疫苗型别抗体的多重免疫测定法的开发与评估
J Immunol Methods. 2015 Feb;417:107-114. doi: 10.1016/j.jim.2014.12.013. Epub 2014 Dec 30.
9
EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection.欧洲国际生殖健康与性传播感染学会2014年路线图：人乳头瘤病毒感染的自然史、传播以及与性别和感染解剖部位相关的人乳头瘤病毒相关癌症发病率的差异
Int J Cancer. 2015 Jun 15;136(12):2752-60. doi: 10.1002/ijc.29082. Epub 2014 Jul 26.
10
Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.谷胱甘肽S-转移酶L1多重血清学作为人乳头瘤病毒累积感染的一种检测方法
BMC Infect Dis. 2014 Mar 3;14:120. doi: 10.1186/1471-2334-14-120.
本文引用的文献
1
Seroprevalence of seven high-risk HPV types in The Netherlands.荷兰七种高危型人乳头瘤病毒的血清流行率。
Vaccine. 2012 Oct 19;30(47):6686-93. doi: 10.1016/j.vaccine.2012.08.068. Epub 2012 Sep 7.
2
Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination.青少年女性接种疫苗前的生殖器 HPV 感染和 HPV 血清学流行情况。
Cancer Epidemiol. 2012 Dec;36(6):519-24. doi: 10.1016/j.canep.2012.07.006. Epub 2012 Aug 17.
3
Age-specific HPV seroprevalence among young females in The Netherlands.荷兰年轻女性中特定年龄段 HPV 血清流行率。
Sex Transm Infect. 2010 Dec;86(7):494-9. doi: 10.1136/sti.2009.041210. Epub 2010 Jun 2.
4
Seroreactivity of 38 human papillomavirus types in epidermodysplasia verruciformis patients, relatives, and controls.表皮发育不良症患者、亲属和对照者中 38 种人乳头瘤病毒类型的血清反应性。
J Invest Dermatol. 2010 Mar;130(3):841-8. doi: 10.1038/jid.2009.356. Epub 2009 Nov 19.
5
Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.美国6型、11型、16型和18型人乳头瘤病毒血清流行率：2003 - 2004年国家健康和营养检查调查
J Infect Dis. 2009 Oct 1;200(7):1059-67. doi: 10.1086/604729.
6
Second national serum bank for population-based seroprevalence studies in the Netherlands.荷兰第二个用于基于人群血清流行率研究的国家血清库。
Neth J Med. 2009 Jul-Aug;67(7):301-8.
7
Seroprevalence of 34 human papillomavirus types in the German general population.德国普通人群中34种人乳头瘤病毒类型的血清流行率。
PLoS Pathog. 2008 Jun 20;4(6):e1000091. doi: 10.1371/journal.ppat.1000091.
8
Prevalence of human papillomavirus antibodies in young female subjects in England.英国年轻女性人群中人乳头瘤病毒抗体的流行情况
Br J Cancer. 2007 Oct 8;97(7):989-91. doi: 10.1038/sj.bjc.6603955. Epub 2007 Aug 28.
9
Suppression of non-specific binding in serological Luminex assays.血清学Luminex检测中非特异性结合的抑制
J Immunol Methods. 2006 Feb 20;309(1-2):200-4. doi: 10.1016/j.jim.2005.11.008. Epub 2005 Dec 19.
10
Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins.基于原位纯化谷胱甘肽S-转移酶融合蛋白的多重人乳头瘤病毒血清学检测
Clin Chem. 2005 Oct;51(10):1845-53. doi: 10.1373/clinchem.2005.052381. Epub 2005 Aug 11.
Zotero 插件